RU2553564C2 - Генетически модифицированный бактериальный штамм wsj-ia, продуцирующий изовалерилспирамицин i с высоким содержанием и высоким выходом - Google Patents

Генетически модифицированный бактериальный штамм wsj-ia, продуцирующий изовалерилспирамицин i с высоким содержанием и высоким выходом Download PDF

Info

Publication number
RU2553564C2
RU2553564C2 RU2012158029/10A RU2012158029A RU2553564C2 RU 2553564 C2 RU2553564 C2 RU 2553564C2 RU 2012158029/10 A RU2012158029/10 A RU 2012158029/10A RU 2012158029 A RU2012158029 A RU 2012158029A RU 2553564 C2 RU2553564 C2 RU 2553564C2
Authority
RU
Russia
Prior art keywords
gene
strain
wsj
ist
streptomyces
Prior art date
Application number
RU2012158029/10A
Other languages
English (en)
Russian (ru)
Other versions
RU2012158029A (ru
Inventor
Игуан ВАН
Ян ЦЗЯН
Шэнву ЯН
Сяофэн ЧЖАО
Original Assignee
Шэнь Ян Тунлянь Груп Ко., Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шэнь Ян Тунлянь Груп Ко., Лтд filed Critical Шэнь Ян Тунлянь Груп Ко., Лтд
Publication of RU2012158029A publication Critical patent/RU2012158029A/ru
Application granted granted Critical
Publication of RU2553564C2 publication Critical patent/RU2553564C2/ru

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • C12N15/03Bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
RU2012158029/10A 2010-07-23 2011-07-21 Генетически модифицированный бактериальный штамм wsj-ia, продуцирующий изовалерилспирамицин i с высоким содержанием и высоким выходом RU2553564C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2010102375954A CN101914482B (zh) 2010-07-23 2010-07-23 一株异戊酰螺旋霉素i组分高含量、高产量基因工程菌
CN201010237595.4 2010-07-23
PCT/CN2011/001194 WO2012009963A1 (zh) 2010-07-23 2011-07-21 用于生产异戊酰螺旋霉素i的基因工程菌wsj-ia

Publications (2)

Publication Number Publication Date
RU2012158029A RU2012158029A (ru) 2014-08-27
RU2553564C2 true RU2553564C2 (ru) 2015-06-20

Family

ID=43322129

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012158029/10A RU2553564C2 (ru) 2010-07-23 2011-07-21 Генетически модифицированный бактериальный штамм wsj-ia, продуцирующий изовалерилспирамицин i с высоким содержанием и высоким выходом

Country Status (11)

Country Link
US (1) US8759032B2 (de)
EP (1) EP2597152B1 (de)
JP (1) JP5719437B2 (de)
KR (1) KR101542243B1 (de)
CN (1) CN101914482B (de)
BR (1) BR112013001580A2 (de)
CA (1) CA2800326C (de)
MX (1) MX342493B (de)
MY (1) MY157302A (de)
RU (1) RU2553564C2 (de)
WO (1) WO2012009963A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101914482B (zh) 2010-07-23 2012-07-04 中国医学科学院医药生物技术研究所 一株异戊酰螺旋霉素i组分高含量、高产量基因工程菌
CN105062948A (zh) * 2015-07-31 2015-11-18 天方药业有限公司 一种制备螺旋霉素碱产生菌生二素灰色链霉菌孢子的方法
CN107868789B (zh) 2015-12-31 2020-11-17 沈阳福洋医药科技有限公司 可利霉素生物合成基因簇
CN106172753A (zh) * 2016-08-23 2016-12-07 山西维尔生物乳制品有限公司 一种液态发酵剂接种装置及方法
CN111349595A (zh) * 2018-12-20 2020-06-30 沈阳福洋医药科技有限公司 一种螺旋霉素产生菌、可利霉素产生菌、构建方法、应用及提高产物产量的方法
WO2024074637A1 (en) * 2022-10-07 2024-04-11 Syngenta Crop Protection Ag Means and methods for controlling pathogens and pests in plants

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7579167B2 (en) * 2002-10-08 2009-08-25 Aventis Pharma S. Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5334788A (en) 1976-09-11 1978-03-31 Sanraku Inc Antibiotics spiramycin derivatives
JP2749616B2 (ja) * 1988-05-24 1998-05-13 メルシャン株式会社 マクロライド抗生物質の4”位アシル化酵素をコードする遺伝子
JPH06121677A (ja) * 1992-01-23 1994-05-06 Mercian Corp マクロライド抗生物質のアシル化酵素遺伝子の高発現方法
EP1905833B1 (de) * 2002-10-08 2015-08-12 Aventis Pharma S.A. Polypeptide, die an der Biosynthese von Spiramycinen beteiligt sind, Nukleotidsequenzen, die diese Polypetide kodieren, und ihre Anwendungen
CN1169947C (zh) * 2002-11-19 2004-10-06 中国医学科学院医药生物技术研究所 必特螺旋霉素的基因工程菌株螺旋霉素链霉菌wsj-195
CN101054553A (zh) * 2007-04-09 2007-10-17 中国医学科学院医药生物技术研究所 异戊酰螺旋霉素i基因工程菌株的构建
CN101649325B (zh) * 2009-07-03 2011-09-07 中国医学科学院医药生物技术研究所 一种提高基因工程异戊酰螺旋霉素主组分含量的基因串连技术
CN101914481B (zh) * 2010-07-23 2013-06-05 中国医学科学院医药生物技术研究所 一株异戊酰螺旋霉素高含量主组分基因工程菌
CN101914482B (zh) 2010-07-23 2012-07-04 中国医学科学院医药生物技术研究所 一株异戊酰螺旋霉素i组分高含量、高产量基因工程菌

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7579167B2 (en) * 2002-10-08 2009-08-25 Aventis Pharma S. Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof
RU2377304C2 (ru) * 2002-10-08 2009-12-27 Авентис Фарма С.А. Полинуклеотид, кодирующий ацилтрансферазу, отвечающую за модификацию платенолида в положении 3 (варианты), полипептид, представляющий собой ацилтрансферазу, отвечающую за модификацию платенолида в положении 3 (варианты), бактериальный экспрессионный вектор (варианты), бактериальная экспрессионная система, бактериальная клетка-хозяин, способ продуцирования полипептида, штамм streptomyces ambofaciens, применение полинуклеотида (варианты), клетка бактерии streptomyces ambofaciens, клетка-хозяин streptomyces ambofaciens и способ получения полипептида

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LI ZL et al., Leucine improves the component of isovalerylIspiramycins for the production of bitespiramycin, Bioprocess Biosyst Eng, August 2009, Vol.32, No.5, pp.641-647. WEI X., et al., Fermentation scale-up experiment of genetically engineered strain of isovaleryl-spiramycin, Chinese journal of natibiotics, June 1996, Vol,21, No.3, pp.180-183. MA C., et al., Construction of 4"-isovalerylspiramycin-I-producing strain by in-frame partial deletion of 3-O-acyltransferase gene in Streptomyces spiramyceticus WSJ-1, the bitespiramycin producer, Curr Microbiol., Epub 19.05.2010, Vol.62, No.2, pp.16-20. *

Also Published As

Publication number Publication date
CA2800326C (en) 2014-09-30
MY157302A (en) 2016-05-31
KR20130091335A (ko) 2013-08-16
BR112013001580A2 (pt) 2016-05-10
US8759032B2 (en) 2014-06-24
KR101542243B1 (ko) 2015-08-05
JP5719437B2 (ja) 2015-05-20
CN101914482B (zh) 2012-07-04
RU2012158029A (ru) 2014-08-27
WO2012009963A1 (zh) 2012-01-26
EP2597152A4 (de) 2014-04-16
CA2800326A1 (en) 2012-01-26
EP2597152A1 (de) 2013-05-29
JP2013532981A (ja) 2013-08-22
US20130130324A1 (en) 2013-05-23
CN101914482A (zh) 2010-12-15
EP2597152B1 (de) 2023-11-01
MX2013000944A (es) 2013-02-27
MX342493B (es) 2016-09-29

Similar Documents

Publication Publication Date Title
RU2553564C2 (ru) Генетически модифицированный бактериальный штамм wsj-ia, продуцирующий изовалерилспирамицин i с высоким содержанием и высоким выходом
CN106497827B (zh) 一种定向生产抗结核活性和抗肿瘤活性化合物的基因工程菌株及其应用
CN104974974B (zh) 一株刺糖多孢菌多杀菌素高产工程菌株及其应用
CN110343709B (zh) 一种北极拟诺卡氏菌套索肽基因簇及其克隆与表达方法
EP3385386A1 (de) Carrimycin-biosynthese-gen-cluster
CN106434702A (zh) 一种帕克特酰胺的生物合成基因簇及其应用
CN103215281B (zh) 一种格瑞克霉素和p-1894b的生物合成基因簇及其应用
WO2019223433A1 (zh) 一种非达霉素基因工程菌及构建方法和应用
CN110832066B (zh) 一种伊维菌素B1b产生菌及其应用
CN110106191A (zh) 人工合成的透明颤菌血红蛋白基因及相应工程菌株和应用
CN112409372B (zh) 玉红霉素类似物、制备方法及其应用
CA2354030A1 (en) Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
CN112430608B (zh) 一种构建奥利万星前体高产工程菌的方法及应用
KR101327798B1 (ko) 아글루코반코마이신을 생산하는 미생물
CN108929860A (zh) 一种产chloroeremomycin的基因工程菌及其制备方法和应用
CN110396521B (zh) Sav6604基因在提高阿维菌素产量中的应用
CN101914481B (zh) 一株异戊酰螺旋霉素高含量主组分基因工程菌
CN111378610B (zh) 一种巴弗洛霉素高产工程菌及其构建和应用
CN108753799B (zh) 一种米尔贝霉素合成正调控基因kelR、编码蛋白、基因工程菌及其制备方法和应用
CN115537367A (zh) 棘白菌素b脱酰基酶的基因工程菌及其制备与应用
KR100357237B1 (ko) 한우 유래 락토페린 발현용 재조합 효모균주 및 이로부터 얻은 재조합 락토페린
CN114574415A (zh) 一种c5-酮基米尔贝霉素生产菌株的构建方法及应用
CN116716233A (zh) 一种生产星形孢菌素的基因工程菌及其制备方法
CN114438004A (zh) 一株pII基因加倍的须糖多孢菌工程菌株及其构建方法与应用
CN111454338A (zh) 塞普霉素前体肽的突变体、其应用及制得的塞普霉素类似物

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20170420